Smith Stan bought MAIA
March 31, 2026 · Form 4 insider transaction
Smith Stan bought 33,099 shares of MAIA Biotechnology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
33,099
Price
$0.00
Total value
N/A
InsiderSmith Stan
Role—
SecurityStock Options
Transaction codeA: Grant or award
Transaction dateMarch 31, 2026
Filing dateApril 2, 2026
Shares owned after33,099
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The stock options, granted on March 31, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.; These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.